🇺🇸 FDA
Patent

US 9115092

Substituted quinazoline and pyrido-pyrimidine derivatives

granted A61KA61K31/535A61P

Quick answer

US patent 9115092 (Substituted quinazoline and pyrido-pyrimidine derivatives) held by Asana BioSciences, LLC expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/535, A61P, A61P1/00, A61P11/00